10K 2003 HEMISPHERX BIOPHARMA, INC.

Company

AIM ImmunoTech Inc.

Filed

March 12, 2004

Period of Report

December 31, 2003

Accession Number

0000946644-04-000002

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →